Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single-cell RNA sequencing Analysis of Treg cells from mouse B16 melanoma tumors

ABSTRACT: Based on single-cell RNA sequencing technology, we studies gene expression profiles in Treg cells isolated from mouse tumors before and after rMVA therapy. We identified differential Treg populations from tumors before and after rMVA therapy. The difference of Treg clusters in tumors were also identified.

ORGANISM(S): Mus musculus

PROVIDER: GSE199371 | GEO | 2023/03/23

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Next Generation Sequencing Analysis of OX40hi Treg and OX40lo Treg cells from mouse tumors and spleens

Project description:Based on RNA-seq technology, we studies gene expression profiles in Treg cells isolated from mouse tumors and spleens. We identified differential gene expressions comparing OX40hi Treg with OX40lo Treg cells from tumors and spleens. The difference of Trges in tumors and spleens were also identified.

2022-12-21 | GSE192563 | GEO

Treg cell gene expression signature in B16 melanoma

Project description:Gene expression signature of Treg cells in B16 melanoma was measured and compared to B16-infiltrating CD4+ Tconv cells and CD8+ T cells as well as splenic Treg cells, CD4+ Tconv cells and CD8+ T cells.

2016-10-31 | GSE87335 | GEO

Single-cell RNA sequencing Analysis of Treg cells from mouse B16 melanoma tumors

Project description:Single-cell RNA sequencing Analysis of Treg cells from mouse B16 melanoma tumors

| PRJNA819465 | ENA

Effect of alisertib and navitoclax on gene expression in B16 melanoma tumors

Project description:To investigate how tumor cells respond to alisertib and navitoclax single agents and combonation therapy in vivo, mice with melanoma were treated with these agents or vehicle-contol. RNAseq was used to investigate gene expression in tumors

2022-10-26 | GSE212127 | GEO

DRAK2 alters IL-2 sensitivity and Treg development

Project description:Drak2¬-deficient (Drak2-/-) mice are resistant to multiple models of autoimmunity, yet effectively eliminate pathogens and tumors. Thus, DRAK2 is an ideal target to treat autoimmune diseases. However, the mechanisms by which DRAK2 contributes to autoimmunity, particularly type 1 diabetes (T1D), remain unresolved. Our data indicate that DRAK2 contributes to autoimmunity in multiple ways by regulating thymic Treg development and by impacting the sensitivity of conventional T cells to Treg-mediated suppression.

2023-02-09 | PXD037922 | Pride

Next Generation Sequencing Analysis of mouse tumors treated with rMVA

Project description:Based on RNA-seq technology, we studies gene expression profiles in tumor lysis isolated from mouse tumors before and after rMVA treatment. We identified differential gene expressions comparing treated tumors with non-treated tumors. The difference of tumor gene expression between WT and STING KO mice were also identified.

2022-11-10 | GSE188496 | GEO

Gene Expression patterns in mouse B16-OVA melanoma tumors

Project description:This laboratory focuses on selectin mediated recruitment during adoptive immunotherapy for metastatic cancer. This study seeks to determine changes in the expression levels of Fucosyltransferases, Selectins, and cytokines in normal and inflamed mouse skin, melanoma tumor tissue of different sizes, and tumor cells grown in culture. Since the ability to treat the tumor effectively is directly related to the size of the tumor, differences in glyco-expression patterns may be of interest. In this study, five groups were hybridized and analyzed using the GLYCOv2 array. Each group was analyzed in triplicate. The groups were: Normal mouse skin, normal mouse skin inflamed by treatment with Oxazolone, B16-OVA melanoma tissue from 6 day tumors, B16-OVA melanoma tissue from 11 day tumors, and B16-OVA grown in cell culture.

2011-02-17 | E-GEOD-27355 | biostudies-arrayexpress

Lipid signalling enforces functional specialization of Treg cells in tumours [scRNA-seq]

Project description:Metabolic reprogramming enforces Treg cell functional specialization in tumors by coordinating fatty acid biosynthesis and inhibitory receptor signaling pathways. These findings point to new avenues to selectively targeting intratumoral Treg cells for cancer therapy.

2021-02-24 | GSE165258 | GEO

Lipid signalling enforces functional specialization of Treg cells in tumours [microarray #2]

2021-02-24 | GSE165257 | GEO

Lipid signalling enforces functional specialization of Treg cells in tumours [microarray #1]

2021-02-24 | GSE149573 | GEO